{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T21:39:50Z","timestamp":1782077990348,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jdin.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T19:25:05Z","timestamp":1644434705000},"page":"125-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Comparing the frequency of isotretinoin-induced hair loss at &lt;0.5-mg\/kg\/d versus \u22650.5-mg\/kg\/d dosing in acne patients: A systematic review"],"prefix":"10.1016","volume":"6","author":[{"given":"Yuliya","family":"Lytvyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1027-1475","authenticated-orcid":false,"given":"Katherine","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asfandyar","family":"Mufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Beecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdin.2022.01.002_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2340\/00015555-1164","article-title":"Prevalence of acne vulgaris in Chinese adolescents and adults: a community-based study of 17,345 subjects in six cities","volume":"92","author":"Shen","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"10.1016\/j.jdin.2022.01.002_bib2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1468-3083.2006.01791.x","article-title":"The prevalence of acne in the north of Portugal","volume":"20","author":"Amado","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jdin.2022.01.002_bib3","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/jid.2009.47","article-title":"Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study","volume":"129","author":"Ghodsi","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.2007.08087.x","article-title":"Community-based study of acne vulgaris in adolescents in Singapore","volume":"157","author":"Tan","year":"2007","journal-title":"Br J Dermatol"},{"issue":"suppl 5","key":"10.1016\/j.jdin.2022.01.002_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.01.002_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2133.1999.02979.x","article-title":"The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals","volume":"141","author":"Goulden","year":"1999","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.002_bib7","first-page":"577","article-title":"Prevalence of facial acne in adults","volume":"41","author":"Goulden","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.01.002_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaad.2007.06.045","article-title":"The prevalence of acne in adults 20 years and older","volume":"58","author":"Collier","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2022.01.002_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1468-3083.2001.00357.x","article-title":"An epidemiological study of acne in female adults: results of a survey conducted in France","volume":"15","author":"Poli","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"suppl 2","key":"10.1016\/j.jdin.2022.01.002_bib10","first-page":"S3","article-title":"The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions","volume":"7","author":"Leyden","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.01.002_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jocd.12800","article-title":"Effects of isotretinoin on the hair cycle","volume":"18","author":"\u0130slamo\u011flu","year":"2019","journal-title":"J Cosmet Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2022.01.002_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.0022-202X.2005.23686.x","article-title":"Towards dissecting the pathogenesis of retinoid-induced hair loss: all-trans retinoic acid induces premature hair follicle regression (catagen) by upregulation of transforming growth factor-beta2 in the dermal papilla","volume":"124","author":"Foitzik","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.002_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/1203475419838553","article-title":"FDA reports of alopecia as an adverse event to isotretinoin","volume":"23","author":"Tkachenko","year":"2019","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jdin.2022.01.002_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1067\/S0190-9622(03)01564-0","article-title":"Oral retinoid therapy for dermatologic conditions in children and adolescents","volume":"49","author":"Brecher","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1440-0960.2012.00947.x","article-title":"Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?","volume":"54","author":"Rademaker","year":"2013","journal-title":"Australas J Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2022.01.002_bib19","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1111\/jdv.16430","article-title":"Comparison of guidelines and consensus articles on the management of patients with acne with oral isotretinoin","volume":"34","author":"Dessinioti","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jdin.2022.01.002_bib20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jdin.2022.01.002_bib21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1365-4632.2005.02284.x","article-title":"Profile of acne patients in the Philippines requiring a second course of oral isotretinoin","volume":"44","author":"Haryati","year":"2005","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2022.01.002_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4103\/0378-6323.86482","article-title":"Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial","volume":"77","author":"Agarwal","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.002_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jaad.2005.11.1061","article-title":"Low-dose isotretinoin in the treatment of acne vulgaris","volume":"54","author":"Amichai","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2022.01.002_bib24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1365-2133.2007.08250.x","article-title":"Isotretinoin therapy and the incidence of acne relapse: a nested case-control study","volume":"157","author":"Azoulay","year":"2007","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.01.002_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-3083.1998.tb00763.x","article-title":"Medium dose isotretinoin for the treatment of acne","volume":"11","author":"Hermes","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2-3","key":"10.1016\/j.jdin.2022.01.002_bib26","first-page":"41","article-title":"Low-dose schema of isotretinoin in acne vulgaris","volume":"23","author":"Mandekou-Lefaki","year":"2003","journal-title":"Int J Clin Pharmacol Res"},{"issue":"2","key":"10.1016\/j.jdin.2022.01.002_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000090658","article-title":"Prospective study of risk factors of relapse after treatment of acne with oral isotretinoin","volume":"212","author":"Quereux","year":"2006","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2133.2011.10440.x","article-title":"Low-dose isotretinoin in acne vulgaris: a critical review","volume":"165","author":"Sardana","year":"2011","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jdin.2022.01.002_bib29","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1365-2133.2010.10152.x","article-title":"Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: a randomized, controlled comparative study","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib30","first-page":"130","article-title":"Treatment of acne vulgaris","volume":"18","author":"James","year":"1958","journal-title":"GP"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sder.2008.07.002","article-title":"Preventing and managing the side effects of isotretinoin","volume":"27","author":"Brelsford","year":"2008","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.jdin.2022.01.002_bib32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1529-8019.2006.00084.x","article-title":"Update in retinoid therapy of acne","volume":"19","author":"Thielitz","year":"2006","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","article-title":"Isotretinoin therapy for acne: results of a multicenter dose-response study","volume":"10","author":"Strauss","year":"1984","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jdin.2022.01.002_bib34","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1365-4632.2011.05409.x","article-title":"High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life","volume":"51","author":"Cyrulnik","year":"2012","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.jdin.2022.01.002_bib35","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","article-title":"High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris","volume":"149","author":"Blasiak","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.01.002_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2010.06.025","article-title":"Could higher doses of isotretinoin reduce the frequency of treatment failure in patients with acne?","volume":"65","author":"Coloe","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.01.002_bib37","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2017.09.078","article-title":"Practical management of acne for clinicians: an international consensus from the Global Alliance to Improve Outcomes in Acne","volume":"78","author":"Thiboutot","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2022.01.002_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ijd.12942","article-title":"Making sense of the effects of the cumulative dose of isotretinoin in acne vulgaris","volume":"55","author":"Rademaker","year":"2016","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.01.002_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1203475415595776","article-title":"Evaluation of evidence for acne remission with oral isotretinoin cumulative dosing of 120-150 mg\/kg","volume":"20","author":"Tan","year":"2016","journal-title":"J Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaad.2020.10.030","article-title":"Analysis of factors associated with relapse in patients on their second course of isotretinoin for acne vulgaris","volume":"84","author":"Tran","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jdin.2022.01.002_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.002_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4103\/jrpp.JRPP_17_30","article-title":"Comparing the efficacy of low dose and conventional dose of oral isotretinoin in treatment of moderate and severe acne vulgaris","volume":"6","author":"Faghihi","year":"2017","journal-title":"J Res Pharm Pract"},{"issue":"8","key":"10.1016\/j.jdin.2022.01.002_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/11539570-000000000-00000","article-title":"Combination of low-dose isotretinoin and pulsed oral azithromycin in the management of moderate to severe acne: a preliminary open-label, prospective, non-comparative, single-centre study","volume":"31","author":"De","year":"2011","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/0019-5154.131455","article-title":"Safety and efficacy of low-dose isotretinoin in the treatment of moderate to severe acne vulgaris","volume":"59","author":"Rao","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/jocd.12268","article-title":"Safety and efficacy of fixed-dose 10 mg daily isotretinoin treatment for acne vulgaris in Malaysia","volume":"16","author":"Yap","year":"2017","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"10.1016\/j.jdin.2022.01.002_bib47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4103\/2229-5178.190505","article-title":"A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris","volume":"7","author":"Dhaked","year":"2016","journal-title":"Indian Dermatol Online J"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib48","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-4632.2004.02072.x","article-title":"Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris","volume":"44","author":"Kus","year":"2005","journal-title":"Int J Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2022.01.002_bib49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00403-007-0777-2","article-title":"Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study","volume":"299","author":"Akman","year":"2007","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.jdin.2022.01.002_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/20786204.2009.10873897","article-title":"Systemic isotretinoin in the management of acne\u2014a patient questionnaire survey","volume":"51","author":"Burger","year":"2014","journal-title":"S Afr Fam Pract"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib51","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/S0365-05962010000300006","article-title":"Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin","volume":"85","author":"Brito","year":"2010","journal-title":"An Bras Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2022.01.002_bib52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-4632.2009.04232.x","article-title":"Influence of isotretinoin on nasal mucociliary clearance and lung function in patients with acne vulgaris","volume":"49","author":"Gorpelioglu","year":"2010","journal-title":"Int J Dermatol"},{"issue":"16","key":"10.1016\/j.jdin.2022.01.002_bib53","first-page":"1877","article-title":"The evaluation of isotretinoin induced adverse drug reactions","volume":"5","author":"Entezari-Maleki","year":"2011","journal-title":"Afr J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.jdin.2022.01.002_bib54","first-page":"38","article-title":"Efficacy and adverse effects of systemic isotretinoin therapy","volume":"21","author":"Tahir","year":"2011","journal-title":"J Pakistan Assoc Dermatologists"},{"issue":"5","key":"10.1016\/j.jdin.2022.01.002_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/09546634.2012.672708","article-title":"Isotretinoin is safe and efficacious in Asians with acne vulgaris","volume":"24","author":"Gan","year":"2013","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.jdin.2022.01.002_bib56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5114\/pdia.2013.39432","article-title":"Evaluation of biophysical skin parameters and assessment of hair growth in patients with acne treated with isotretinoin","volume":"30","author":"Kmie\u0107","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"issue":"8","key":"10.1016\/j.jdin.2022.01.002_bib57","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/09546634.2019.1577545","article-title":"Is there an association between isotretinoin therapy and adverse mood changes? A prospective study in a cohort of acne patients","volume":"30","author":"Bray","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"65","key":"10.1016\/j.jdin.2022.01.002_bib58","first-page":"14","article-title":"Efficacy of isotretinoin and antihistamine versus isotretinoin alone in the treatment of moderate to severe acne: a randomised control trial","volume":"17","author":"Pandey","year":"2019","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.002_bib59","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-0960.2010.00657.x","article-title":"Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin","volume":"51","author":"Rademaker","year":"2010","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.002_bib60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09546634.2016.1230175","article-title":"The weeks and the cumulative doses of the first adverse events related to oral isotretinoin in acne patients: analysis of 300 patients","volume":"28","author":"Demirseren","year":"2017","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jdin.2022.01.002_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12483","article-title":"Adverse effects of isotretinoin: a large, retrospective review","volume":"30","author":"Brzezinski","year":"2017","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib62","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jsps.2020.01.019","article-title":"Prevalence and associated risk factors of acne relapse among Saudi acne vulgaris patients using isotretinoin","volume":"28","author":"Alshammari","year":"2020","journal-title":"Saudi Pharm J"},{"issue":"5","key":"10.1016\/j.jdin.2022.01.002_bib63","article-title":"Telogen effluvium: a review of the literature","volume":"12","author":"Asghar","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jdin.2022.01.002_bib64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archderm.1993.01680240096017","article-title":"Telogen effluvium: new concepts and review","volume":"129","author":"Headington","year":"1993","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.jdin.2022.01.002_bib65","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.det.2007.01.005","article-title":"Drug reactions affecting hair: diagnosis","volume":"25","author":"Tosti","year":"2007","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.jdin.2022.01.002_bib66","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2133.1997.17771864.x","article-title":"Treatment of acne with intermittent isotretinoin","volume":"137","author":"Goulden","year":"1997","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jdin.2022.01.002_bib67","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1468-3083.2006.01784.x","article-title":"The effectiveness of intermittent isotretinoin treatment in mild or moderate acne","volume":"20","author":"Kaymak","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328722000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:59:50Z","timestamp":1762981190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328722000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":63,"alternative-id":["S2666328722000050"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2022.01.002","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg\/kg\/d versus \u22650.5-mg\/kg\/d dosing in acne patients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}